tki
Showing 1 - 8 of 8
Oligometastatic Disease, NSCLC, Driver Mutation Trial in Mumbai (Local Consolidative Radiation Therapy, TKI)
Recruiting
- Oligometastatic Disease
- +2 more
- Local Consolidative Radiation Therapy
- TKI
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Mar 11, 2022
Withdrawal of Second-generation Tyrosine Kinase Inhibitors After
Recruiting
- MMR on 12 Month
- TKI
-
Guangzhou, Guangdong, China
- +1 more
Apr 21, 2022
Unresectable Hepatocellular Carcinoma Trial in Beijing (Camrelizumab, HAIC, TKI)
Recruiting
- Unresectable Hepatocellular Carcinoma
- Camrelizumab
- +2 more
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 22, 2021
Stage IV NSCLC Trial in Wuhan (SBRT+TKI, TKI)
Completed
- Stage IV Non-small Cell Lung Cancer
- SBRT+TKI
- TKI
-
Wuhan, Hubei, ChinaTongji Hospital of Tongji Medical College of Huazhong University
Apr 5, 2021
Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (HAIC of 130 mg/m² Oxaliplatin, and 5-fu, HAIC of 85 mg/m² Oxaliplatin, and
Recruiting
- Hepatocellular Carcinoma
- HAIC of 130 mg/m² Oxaliplatin, and 5-fu
- +2 more
-
Guangzhou, Guangdong, China
- +2 more
Jan 12, 2021
NSCLC Trial in United Kingdom (SBRT, TKI)
Unknown status
- NSCLC
- SBRT
- TKI
-
Sutton, England, United Kingdom
- +5 more
Oct 19, 2018
Non-Small Cell Adenocarcinoma, Tyrosine Kinase Mutation, EGFR Gene Mutation Trial in Mexico (Metformin, TKI)
Unknown status
- Non-Small Cell Adenocarcinoma
- +2 more
- Metformin
- TKI
-
Mexico, MexicoInstituto National de Cancerologia
Mar 1, 2017
Lung Adenocarcinoma Trial in Hangzhou (TKI, Thoracic Hypofractionated Radiotherapy, Thymosin Alpha 1)
Unknown status
- Lung Adenocarcinoma
- TKI
- +2 more
-
Hangzhou, Zhejiang, ChinaHangzhou First People's Hospital
Nov 23, 2016